Cargando…
Does Erythropoietin Cause Hemoglobin Variability- Is It ‘Normal’?
Hemoglobin variability (Hb-var) in patients with chronic kidney disease has been stipulated to be a result of exogenous treatment with erythropoiesis stimulating agents (ESA) and has been related to mortality in dialysis patients. We hypothesized the existence of Hb-var independent of ESA administra...
Autores principales: | Gupta, Ashwani K, David, Waseem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977846/ https://www.ncbi.nlm.nih.gov/pubmed/24709756 http://dx.doi.org/10.1371/journal.pone.0092890 |
Ejemplares similares
-
Effects of the route of erythropoietin administration on hemoglobin variability and cardiovascular events in hemodialysis patients
por: Kim, Do Hyoung, et al.
Publicado: (2021) -
Hemoglobin and Erythropoietin After Commercial Saturation Diving
por: Kiboub, Fatima Z., et al.
Publicado: (2018) -
ERYTHROPOIETIN EFFECTS ON FETAL MOUSE ERYTHROID CELLS : I. Cell Population and Hemoglobin Synthesis
por: Chui, David H. K., et al.
Publicado: (1971) -
Comparison of Hemoglobin Levels Before and After Hemodialysis and Their Effects on Erythropoietin Dosing and Cost
por: Sagheb, Mohammad Mahdi, et al.
Publicado: (2016) -
Gender Differences in Dose of Erythropoietin to Maintain Hemoglobin Target in Hemodialysis Patients
por: Coronado Daza, J. A., et al.
Publicado: (2019)